Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

A kind of porcine circovirus type 2 immune protection polypeptide and vaccine

A porcine circovirus, immune protection technology, applied in the direction of viral peptides, viruses, antiviral agents, etc., can solve the problem of no relevant immune protection

Active Publication Date: 2017-06-27
NANJING AGRICULTURAL UNIVERSITY
View PDF2 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] In order to solve the problem of whether the PCV2 Cap protein antigen has a relevant immune protection effect in the above prior art, the present invention provides a porcine circovirus type 2 immune protection polypeptide

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of porcine circovirus type 2 immune protection polypeptide and vaccine
  • A kind of porcine circovirus type 2 immune protection polypeptide and vaccine
  • A kind of porcine circovirus type 2 immune protection polypeptide and vaccine

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0024] Embodiment 1: Polypeptide and vaccine preparation

[0025] Main Reagents and Materials

[0026] Porcine circovirus type 2 (PCV2) SH strain was isolated, identified and preserved in our laboratory; ISA50V adjuvant was purchased from SEPPIC, France; goat anti-mouse IgG-HRP, SPA-HRP and DAB chromogenic kits were purchased from Wuhan Boster Biotech Engineering company; other routinely used reagents are domestic or imported analytically pure.

[0027] Peptide Sequence and Synthesis

[0028] According to the amino acid sequence of PCV2 Cap protein epitope and T cell epitope, the following 4 polypeptides were designed and synthesized by Shanghai Moxi Biotechnology Co., Ltd. with a purity of more than 90%.

[0029] : as shown in sequence 1 in the sequence table,

[0030] P5013: as shown in sequence 2 in the sequence listing,

[0031] P2914: as shown in sequence 3 in the sequence listing,

[0032] P1300: as shown in sequence 4 in the sequence listing.

[0033] 1.3 Vaccine ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention relates to the technical field of porcine circovirus, in particular to a porcine circovirus 2 (PCV2) immune protection polypeptide, and a vaccine containing the PCV2 immune protection polypeptide. The amino acid sequence of the PCV2 immune protection polypeptide is shown in the sequence table 1-4. According to the vaccine, tests show that after 42-63 days of first immune of a vaccine of P5013 and a vaccine of P1300, the antibody titer and the neutralizing antibody titer of an ELISA antibody are remarkably increased, the lymphocyte proliferative response and IL-4 and IFN-Gamma cytokines are significantly higher than those of a control group, and the antibody level and the cellular immunity level of the vaccine group of P5013 are the highest; mice tests show that PCV2 immune response induced by the synthetic peptide vaccine of P5013 is the highest and the strongest; pig tests find that the synthetic polypeptide vaccine of P5013 can induce pigs to generate a PCV2-specific immune response, can reduce viremia caused by PCV2 virulent virus attack, alleviate the clinical symptoms and pathological lesions of viremia, and has immune protection effect on PCV2.

Description

technical field [0001] The invention relates to the technical field of porcine circovirus, in particular to a porcine circovirus type 2 immune protection polypeptide and a vaccine prepared by using the porcine circovirus type 2 immune protection polypeptide. Background technique [0002] Porcine circovirus type 2 (Porcine circovirus 2, PCV2) is a member of the Circovirus genus of the family Circoviridae, which can cause a variety of diseases such as multisystemic wasting syndrome (PMWS) and porcine dermatitis nephropathy syndrome (PDNS) in weaned piglets. It has brought huge economic losses to the global pig industry. Cap protein is a type-specific antigen of PCV2, which has good immunogenicity, can effectively produce neutralizing antibodies through immunization, neutralize virus infection, and effectively induce protective immune responses against virus attack. At present, commercialized vaccines include inactivated PCV2 vaccine and inactivated PCV2 baculovirus vaccine, b...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C07K14/01A61K39/12A61P31/20
CPCA61K39/00C07K14/005C12N2750/10022C12N2750/10034
Inventor 姜平白娟
Owner NANJING AGRICULTURAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com